slotkoers
Taipei Exchange
00:00:00 08-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
191
TWD
|
+5,52%
|
|
+5,52%
|
+3,52%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
6.865
|
8.244
|
26.551
|
31.104
|
36.132
|
20.911
|
Bedrijfswaarde
1 |
6.211
|
7.622
|
25.549
|
30.393
|
35.168
|
20.045
|
K/w-verhouding
|
-60,9
x
|
-75,1
x
|
-273
x
|
-255
x
|
-140
x
|
-207
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
110.731
x
|
33.242
x
|
31.874
x
|
27.213
x
|
31.611
x
|
1.105
x
|
Bedrijfswaarde/omzet
|
100.179
x
|
30.732
x
|
30.671
x
|
26.590
x
|
30.768
x
|
1.060
x
|
Bedrijfswaarde/EBITDA
|
-52,9
x
|
-61,9
x
|
-231
x
|
-269
x
|
-139
x
|
-160
x
|
Bedrijfswaarde/FCF
|
-41,2
x
|
-213
x
|
-270
x
|
-127
x
|
-138
x
|
-855
x
|
FCF Yield
|
-2,42%
|
-0,47%
|
-0,37%
|
-0,79%
|
-0,73%
|
-0,12%
|
Price to Book
|
8,93
x
|
12,4
x
|
24,3
x
|
32
x
|
26
x
|
15,9
x
|
Aantal aandelen (in duizenden)
|
102.774
|
103.063
|
109.265
|
109.908
|
113.088
|
113.336
|
Referentieprijs
2 |
66,80
|
79,99
|
243,0
|
283,0
|
319,5
|
184,5
|
Datum van publicatie
|
29-04-19
|
17-04-20
|
14-04-21
|
14-04-22
|
24-04-23
|
12-04-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
0,062
|
0,248
|
0,833
|
1,143
|
1,143
|
18,92
|
EBITDA
1 |
-117,5
|
-123,2
|
-110,6
|
-112,8
|
-252,2
|
-125
|
Bedrijfsresultaat (EBIT)
1 |
-123,8
|
-128,8
|
-117,4
|
-120,8
|
-260,7
|
-133,3
|
Operationele Marge
|
-199.758,06%
|
-51.944,76%
|
-14.089,56%
|
-10.570,95%
|
-22.806,74%
|
-704,87%
|
Resultaat voor belastingen (EBT)
1 |
-114
|
-115,3
|
-99,32
|
-114,7
|
-292,1
|
-101,2
|
Nettowinst (verlies)
1 |
-110,7
|
-109,8
|
-93,07
|
-121,6
|
-254,2
|
-101,2
|
Nettomarge
|
-178.624,19%
|
-44.283,87%
|
-11.173,11%
|
-10.637,01%
|
-22.238,76%
|
-534,89%
|
WPA
2 |
-1,097
|
-1,066
|
-0,8909
|
-1,110
|
-2,287
|
-0,8932
|
Free Cash Flow
1 |
-150,6
|
-35,78
|
-94,65
|
-239,9
|
-255,3
|
-23,45
|
FCF-marge
|
-242.874,8%
|
-14.428,58%
|
-11.362,21%
|
-20.992,98%
|
-22.332,13%
|
-124%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
29-04-19
|
17-04-20
|
14-04-21
|
14-04-22
|
24-04-23
|
12-04-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
654
|
622
|
1.003
|
711
|
964
|
865
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-151
|
-35,8
|
-94,6
|
-240
|
-255
|
-23,5
|
ROE (netto-inkomsten/eigen vermogen)
|
-17%
|
-15,6%
|
-10,9%
|
-12,3%
|
-24,7%
|
-7,54%
|
ROA (netto-inkomsten/totale activa)
|
-9,75%
|
-9,43%
|
-7,41%
|
-6,36%
|
-11,7%
|
-5,31%
|
Totale activa
1 |
1.136
|
1.165
|
1.255
|
1.913
|
2.179
|
1.905
|
Nettoactief per aandeel
2 |
7,480
|
6,460
|
10,00
|
8,830
|
12,30
|
11,60
|
Cashflow per aandeel
2 |
1,670
|
1,840
|
6,470
|
4,130
|
5,940
|
2,410
|
Capex
1 |
59,3
|
8,32
|
30,1
|
123
|
7,34
|
0,91
|
Capex/omzet
|
95.611,29%
|
3.356,45%
|
3.617,77%
|
10.762,2%
|
641,91%
|
4,79%
|
Datum van publicatie
|
29-04-19
|
17-04-20
|
14-04-21
|
14-04-22
|
24-04-23
|
12-04-24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +3,52% | 668 mln. | | +2,93% | 108 mld. | | +0,73% | 23,46 mld. | | -14,60% | 21,72 mld. | | -7,05% | 18,64 mld. | | -38,55% | 17,45 mld. | | -8,83% | 17,19 mld. | | +5,51% | 13,99 mld. | | +37,49% | 12,53 mld. | | +329,39% | 8,81 mld. |
Biotherapeutische geneesmiddelen
|